A total of 664 T2D-ESKD cases and 918 non-diabetic non-nephropathy controls were excluded from stage 1 analysis, leaving 2768 T2D-ESKD cases and 6059 controls in the APOL1-negative model. Here, APOL1 is linked to kidney disorder.